Sign in

CIK 0001472091

  • Non-accelerated filer
  • Smaller reporting company

PDS Biotechnology Corp

Sign in to watch
Ticker
PDSB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
264231384
Phone
+1 800-208-3343
Business address
303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
Former names
Edge Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2017-07-03 Leuthner Brian A President and CEO Sale −2,500 $10.27 $26K 132,736
2017-06-20 BARER SOL J Director Grant or award · Stock Option (right To Purchase) +30,000 $10.15 $305K 30,000
2017-06-20 BLECH ISAAC Director Grant or award · Stock Option (right To Purchase) +15,000 $10.15 $152K 15,000
2017-06-20 Conti Kurt G Director Grant or award · Stock Option (right To Purchase) +15,000 $10.15 $152K 15,000
2017-06-20 HEALY JAMES Director Grant or award · Stock Option (right To Purchase) +15,000 $10.15 $152K 15,000
2017-06-20 LOUGHLIN JAMES J Director Grant or award · Stock Option (right To Purchase) +15,000 $10.15 $152K 15,000
2017-06-20 Ratcliffe Liam Director Grant or award · Stock Option (right To Purchase) +15,000 $10.15 $152K 15,000
2017-06-20 Spiegel Robert J. Director Grant or award · Stock Option (right To Purchase) +15,000 $10.15 $152K 15,000
2017-04-26 Leuthner Brian A President and CEO Sale −100 $11.10 $1K 135,236
2017-03-13 MIDDLEKAUFF W BRADFORD Senior VP, GC and Secretary Grant or award · Stock Option (right To Purchase) +52,500 $8.86 $465K 52,500
2017-03-13 Macdonald R. Loch Chief Scientific Officer Grant or award · Stock Option (right To Purchase) +110,000 $8.86 $975K 110,000
2017-03-13 MARCHIO ALBERT N II Chief Accounting & Ops Officer Grant or award · Stock Option (right To Purchase) +47,500 $8.86 $421K 47,500
2017-03-13 Leuthner Brian A President and CEO Grant or award · Stock Option (right To Purchase) +267,500 $8.86 $2.4M 267,500
2017-03-13 Faleck Herbert J Chief Medical Officer Grant or award · Stock Option (right To Purchase) +110,000 $8.86 $975K 110,000
2017-03-13 Yaman Alpaslan V.P., Technical Ops. & Mfg. Grant or award · Stock Option (right To Purchase) +40,000 $8.86 $354K 40,000
2017-03-06 LOUGHLIN JAMES J Director Purchase +3,000 $9.24 $28K 6,000
2017-03-01 Einhorn Andrew J. Chief Financial Officer Option exercise +1,567 $2.39 $4K 43,223
2017-03-01 Einhorn Andrew J. Chief Financial Officer Option exercise · Warrants (right To Purchase) −1,567 0
2017-03-01 Wyant Alyssa SVP Regulatory Affairs Grant or award · Stock Option (right To Purchase) +80,000 $9.81 $785K 80,000
2017-02-07 Leuthner Brian A President and CEO Sale −1,500 $9.52 $14K 245,479

Page 12 of 18 · 346 trades